Gold(III) Complexes as Potential Antitumor Agents: Solution Chemistry and Cytotoxic Properties of Some Selected Gold(III) Compounds
- 1 September 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (19) , 3541-3548
Abstract
Gold(III) complexes generally exhibit interesting cytotoxic and antitumor properties, but until now, their development has been heavily hampered by their poor stability under physiological conditions. To enhance the stability of the gold(III) center, we prepared a number of gold(III) complexes with multidentate ligands − namely [Au(en)2]Cl3, [Au(dien)Cl]Cl2, [Au(cyclam)](ClO4)2Cl, [Au(terpy)Cl]Cl2, and [Au(phen)Cl2]Cl − and analyzed their behavior in solution. The solution properties of these complexes were monitored by visible absorption spectroscopy, mass spectrometry, and chloride-selective potentiometric measurements; the electrochemical properties were also studied by cyclic voltammetry and coulometry. Since all the investigated compounds exhibited sufficient stability under physiological conditions, their cytotoxic properties were tested in vitro, via the sulforhodamine B assay, on the representative human ovarian tumor cell line A2780, either sensitive or resistant to cisplatin. In most cases the investigated compounds showed relevant cell-killing properties with IC50 values falling in the 0.2−10 μM range; noticeably most investigated gold(III) complexes were able to overcome, to a large extent, resistance to cisplatin when tested on the corresponding cisplatin-resistant cell line. The cytotoxic properties of the free ligands were also determined under the same solution conditions. Ethylenediamine, diethylenetriamine, and cyclam were virtually nontoxic (IC50 values > 100 μM) so that the relevant cytotoxic effects observed for [Au(en)2]Cl3 and [Au(dien)Cl]Cl2 could be quite unambiguously ascribed to the presence of the gold(III) center. In contrast the phenanthroline and terpyridine ligands turned out to be even more cytotoxic than the corresponding gold(III) complexes rendering the interpretation of the cytotoxicity profiles of the latter complexes less straightforward. The implications of the present findings for the development of novel gold(III) complexes as possible cytotoxic and antitumor drugs are discussed.Keywords
This publication has 11 references indexed in Scilit:
- Structure and DNA binding properties of the gold(III) complex [AuCl2(esal)]Inorganica Chimica Acta, 1999
- Gold(III) compounds as potential antitumor agents: Cytotoxicity and DNA binding properties of some selected polyamine-gold(III) complexesInorganica Chimica Acta, 1998
- Chemical and Biological Studies of Dichloro(2-((dimethylamino)methyl)phenyl)gold(III)Inorganic Chemistry, 1996
- Antitumor Properties of Some 2-[(Dimethylamino)methyl]phenylgold(III) ComplexesJournal of Medicinal Chemistry, 1996
- The Chemistry of Gold DrugsMetal-Based Drugs, 1994
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Structure of trichloro(diethylenetriamine)gold(III), Au(dien)Cl4, determined by single-crystal x-ray diffraction, Raman and EXAFS spectroscopies: an EXAFS caveatInorganic Chemistry, 1986
- Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activitiesThe American Journal of Medicine, 1983
- Studies in aromatic nitration. 2. Nitrogen-14 NMR study of the nitric acid/nitronium ion equilibrium in aqueous sulfuric acidJournal of the American Chemical Society, 1983
- The Heats of Combustion of Compounds Containing the Tetrazole Ring1Journal of the American Chemical Society, 1951